My Hypothesis that Long Hauler's is a Type III Hyper

New Post Public Reply Private Reply Replies (1) Message Board
MGK_2
645
My Hypothesis that Long Hauler's is a Type III Hyper Sensitivity Reaction & a Possible MOA for LL

I've been thinking about this for some time now.

I really believe that Long Hauler Covid is actually a Type 3 Hyper Sensitivity Reaction.

In Type 3, there are Free Antibodies floating in the blood plasma. They are called Serum Immune Complexes. They are antigen-antibody complexes. For long haulers, the antigen-antibody complex would be the more numerous <covid 19 Spike protein mated with the antibody our body made against the spike protein> OR less in number <covid 19 Spike protein mated with the vaccination antibody given to us in vaccine>.

Type 3 is a rather delayed reaction.

Type 1 is fastest, such as after a bee sting, which could be immediate anaphylaxis or an asthma, angioedema, (usually humoral pre-formed antibodies, IgE, eosinophil mediated, mast cell, histamine),

Type 2 is like Type 3 with antigen-antibody complex, but it is not free floating in the blood. Rather, the complex is attached to the cell, so it is cytotoxic. An example of this hypersensitivity reaction is when your body rejects organs in Graft vs. Host Disease, or Myasthenia Gravis / Pemphigus Vulgaris which are more delayed than immediate.

Type 4, is cell to cell mediated hypersensitivity. The T cells do the killing, not the antibody. Here T Cells and Cytokines, CD4 T lymphocytes secrete interferon gamma which stimulate macrophages to make a granuloma. It is the most delayed and the slowest because it takes a long time to make a granuloma which are found in Tuberculosis, histoplasmosis, coccidiomycosis or Sarcoidosis.

Long Covid is right up this time range. It comes on 2-3 weeks after a person had covid and can last for months to years it seems.

Since the antigen-antibody complex is in the blood, it is circulating through out the body. This complex can end up being deposited in the wall of the blood vessels causing Vasculitis, into the joints, causing immune-complex Arthritis which is what happens in Rheumatoid Arthritis & Lupus, they can get stuck in the kidneys, causing immune-complex mediated Nephritis, in the liver causing Hepatitis (children found with hepatitis following vaccination), in the heart, causing myoCarditis (following covid and following vaccine), etc, etc. All of these are common in Long Covid and even following vaccination.

Type 3 could be a generalized reaction all over the body or it could be a localized reaction. When these antigen-antibody complexes are deposited all over the body, into all the tissues and organs, the Complement Cascade system is activated via IgM antibody 1st and IgG 2nd response, (very good at Complement Activation) and subsequently, the patient gets a shit load of C-complements (proteins) into the blood as well. Complements are proteins made by the liver, leading to the complement cascade which results in the MAC which attacks all foreigners. This Complement System acts like a link or a bridge between the Innate and Adaptive Immunity. Complements are made by the liver to help fight the invader, the antigen-antibody complex. The end result of the Complement Cascade results in an entity called the Membrane Attack Complex, MAC which destroys the antigen-antibody complex. But, in a massive overload situation, they may destroy the tissues as well. Why? Because these complexes are deposited in the tissues of the body.

In a massive overload situation as in long covid (long term), or post vaccination syndrome, (short term), this could result in Hypocomplementemia because all the complements are being consumed being used over and over and over again, to destroy the myriad of antigen-antibody complexes imbedded in the tissues. A real life example of hypocomplementemia is lupus, an auto-immune disease where the body creates MAC, but there are no antigen-antibody complexes, so the body is attacking itself, destroying its own tissues. Many Rheumatological disease like RA have increased complement which leads to joint deformity, kidney disease glomerulonephritis, vascular, endocarditis, myocarditis, vasculitis.

Another idea here is that if the liver is weakened by the huge deposition of antibody-antigen complexes and it is spurred into manufacture of all these complements, but it can not do so because it is itself infected with the antibody-antigen complexes and is therefore unable to develop the building blocks of the MACs via the cascade. That would mean that the only way to get rid of these antibody-antigen complexes is either waiting for them to disintegrate in the tissues or by our Natural Killer Cells.

One test to determine if there is a Complement Deficiency in Long Covid would be the CH50 test. It's a screening test of the Markers which indicate the cascade. If it is low, then order the Early Complement Level. We would expect C4 to be low for it to indicate a Classical Pathway, (auto-immune) pointing to Long Covid or post viral.

There is a complement system regulating protein called Decay Accelerating Factor (DAF) which, on the cell's surface, inhibits both complement 3 convertase and complement 5 convertase; another action is to inhibit Natural Killer Cells, both of which may be how the cells are protected from getting destroyed by the complements. DAF interferes with the escalation of the complement cascade whos final result is the Membrane Attack Complex, (MAC); MAC fails to develop.

I'm guessing here, but I'm considering that Leronlimab may have an effect in upregulation of DAF so the tissues can heal while the antigen-antibody complexes get destroyed by Natural Killer Cells which we already know are suppressed by T regulator cells when Leronlimab is given. So Leronlimab may have a double effect on curbing the onslaught on these antigen-antibody complexes, but may prolong the time it takes to get rid of them.

Leronlimab, being a CCR5 blockade, binds to CCR5 with greatest affinity. Therefore, when it is introduced, it displaces any other cytokine attached to CCR5. This gains control of the Natural Killer Cells. It seems to have a regulating effect. A taming effect, reducing the rampant destruction of everything and anything that it doesn't like.

I suspect Leronlimab achieves this Taming Effect on our Immune Response by Activation of the Tregulatory Cells, the T suppressor cells. By activation of these T helper cells, the Immune Cascade is Tamed, it is quieted, it is quelled leading to less inflammation, less swelling, fewer side effects of the war, fewer symptoms. T regs prevent the attack upon our own cells and develop "Tolerance" of what is "Self" vs. "Non-Self or Foreign" thereby preventing Auto-Immune Disease which in effect a form of this Type III Hypersensitivity Reaction. Does Long Covid = Auto-Immune Disease???

AIDS, Acquired ImmunoDeficiency Syndrome is the attack on CD4+ T-Lymphocytes. That is an attack on T helper cells. T regulatory / T suppressor cells. When you kill these T helper lymphocytes, you kill the Adaptive Immune System. No help. B Lymphocytes are left clueless. Natural Killer cells are clueless. Leronlimab shuts down HIV 1 attack, (not HIV 2), and therefore eradicates AIDS when caused by HIV 1.

I think, although we most definitely can say that Leronlimab is a CCR5 blockade, we should probably say the its Mechanism of Action in the majority of its indications will be a T helper cell regulator. T helper cells help other T cells. It also helps Humoral Immunity by helping the B lymphocytes. T helper cells help T cytotoxic cells kill. They help T regulatory cells control/suppress/regulate the cell mediated attack. (T suppressor cells are now called T regulator cells and they help the immune system do its job, but they can suppress it too, so that the immune system does not kill self.) Leronlimab permits the passive response of the immune system, (memory, production of antibodies), while cutting down on the flank attack, (Tcytotoxic cells, Natural Killer Cells), therefore allows the generalized work of getting to the core of the problem without inducing secondary harm in the process. Therefore, the "real" Mechanism of Action that Leronlimab Helps the T helper cell. CCL5 RANTES is main deceiver of the T helper cell, but Leronlimab displaces CCL5 RANTES from its control of this incredibly important component of Cell-mediated Active Immunity and restores appropriate control of this cellular- immunoregulation necessary to promote recognition of self vs. non self.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Simple Home Upgrades That Boost Value Fast

Updated Category News Views 21

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
xFusion Tackles Cooling and Power at OCP 2026

Updated Category News Views 4

Bracing for an AI Revolution Ah, the world of AI — it's like the wild west out there, with data centers struggling to keep up as workloads skyrocket. Enter xFusion, a veteran in the computing infrastructure game, rolling out some seriously impressive tech at the 2026 Open Compute Project (OCP) Global Summit. The company's latest offering showcases how they're tackling...

Continue Reading
A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Updated Category News Views 6

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 11

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Vayo Debuts as Booking Holdings Eyes $100M Investment

Updated Category News Views 3

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 32

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 5

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 6

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 17

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 0

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading

Top 5 Most Recently Viewed Articles

Stuart Van Houten to Lead BlackLine's Global Sales Strategy

Updated Category News Views 168

Welcoming a New Era at BlackLine BlackLine, Inc. (NASDAQ: BL), a leader in digital finance transformation for the Office of the CFO, is making waves with the recent announcement of Stuart Van Houten as its new Chief Commercial Officer, effective February 17, 2025. As a seasoned veteran in technology and enterprise SaaS, Van Houten's appointment marks a pivotal moment for...

Continue Reading
pharosIQ Enhances atlasIQ for Revolutionary B2B Buyer Insights

Updated Category News Views 258

Transforming B2B Marketing with Enhanced Buyer Insights pharosIQ, recognized as a frontrunner in first-party intent-driven lead generation solutions, is making waves in the B2B marketing landscape with its latest advancements in atlasIQ. This innovative platform is designed to deliver an unprecedented level of visibility into buyer activities globally. B2B marketers now...

Continue Reading
Starr Appoints Peter Hirs as New Chief Financial Officer

Updated Category News Views 328

Starr Welcomes Peter Hirs as the New CFO Starr has officially appointed Peter Hirs as its chief financial officer, marking a significant transition for the company. His appointment comes as Howard I. Smith retires after an impressive 40-year career with the company and its affiliates. Effective immediately, Hirs is set to take the lead in guiding the company through its...

Continue Reading
PKF Investment Banking Expands Leadership with New VP Mark Gianfalla

Updated Category News Views 175

PKF Investment Banking Welcomes New Leadership New Vice President's M&A expertise and multidisciplinary background strengthen firm's deal execution capabilities Introduction of Mark Gianfalla PKF Investment Banking (PKFIB) is thrilled to announce the appointment of Mark Gianfalla as Vice President. In his new role, Mark will concentrate primarily on executing mergers and...

Continue Reading
SWS Medical: Innovating Healthcare Solutions for Africa

Updated Category News Views 349

SWS Medical: Innovating Healthcare Solutions for Africa SWS Medical, a premier provider of blood purification solutions, has established a strong commitment to enhancing healthcare throughout Africa. With a legacy spanning over two decades, SWS Medical has become synonymous with advanced dialysis technologies and has proudly extended its reach to more than 80 countries....

Continue Reading